Join our newsletter! 
 
Emerald Health Pharmaceuticals (EHP) is making great strides in the discovery, development and commercialization of proprietary cannabinoid-derived medicines that address significant unmet needs. Sign up below to receive the latest news from EHP, including press releases, product development, scientific publications, events and financial reporting directly to your inbox.
* indicates required